7 reports

  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Cisplatin Major Producer and Their Market Share

China’s demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Cancer
  • Chemotherapy
  • Pharmaceutical
  • Skin Cancer
  • Dezhou Deyao Pharmaceutical Co., Ltd
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Cisplatin Major Producer and Their Market Share

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Cancer
  • Chemotherapy
  • Skin Cancer
  • Therapy
  • Dezhou Deyao Pharmaceutical Co., Ltd
  • CHAPTER III CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Cervical Cancer Treatment Drugs Production and Demand

The Cervical Cancer Chapter V CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK Treatment Drugs industry is one of the pillar industries in China.

  • Cancer
  • Cervical Cancer
  • Pharmaceutical
  • Dezhou Deyao Pharmaceutical Co., Ltd
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • CHAPTER III CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

It can control the spread of cancer cells, and extend the life time of patients who are ill with cervical cancer.

  • Cancer
  • Cervical Cancer
  • Pharmaceutical
  • Dezhou Deyao Pharmaceutical Co., Ltd
  • Eli Lilly & Co.
  • CHAPTER IV OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

One agent which seems to be promising is cannabidiol, a non-toxic substance found in cannabis which has been found to reduce growth and invasiveness of cancer cells in vitro.

  • Cancer
  • Chemotherapy
  • Ovarian Cancer
  • Therapy
  • Dezhou Deyao Pharmaceutical Co., Ltd
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development
  • Toll Like Receptor 8 (CD288 or TLR8) - Dormant Products

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.